Dr. Michael Lawrence Metzger, MD

Dr. Metzger practices at South Palm Cardiovascular Associates in Delray Beach, Florida.

Dr. Metzger's NPI, 1235253899, was assigned on March 19, 2007. Dr. Metzger graduated from Tel Aviv University Sackler in 2000. Dr. Metzger holds Florida license ME0097956.

Dr. Metzger's primary practice is South Palm Cardiovascular Associates, at 13550 S Jog Rd, Delray Beach, FL 33446 in Palm Beach County. The practice phone is (561) 515-0080.

Dr. Metzger's primary practice is South Palm Cardiovascular Associates in Delray Beach, Florida. Dr. Metzger is also affiliated with Delray Medical Center. The medical group on file is South Palm Cardiovascular Associates. Dmand AI also links Dr. Metzger to 2 more hospitals, 3 group practices and clinics, 2 medical groups and 1 physician office, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Metzger practices, 7 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Metzger's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Metzger is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Dr. Metzger's licenses on file in 2 states: Florida and Pennsylvania.

Dmand AI lists aneurysm, angioplasty, atrial fibrillation and flutter, cardiac catheterization, cardiomyopathy, cerebrovascular disease, chronic embolism thrombosis and chronic hypertension among the conditions Dr. Metzger treats.

CMS data shows 18,702 Medicare services from Dr. Metzger across 48 procedure codes in 2024, for 2,684 Medicare patients. Medicare paid $1,826,331 for them.

CMS counts 2,684 Medicare patients who saw Dr. Metzger in 2024. The largest group is 75 to 84, with 1,231 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 6% are also on Medicaid. Their average risk score is 1.90, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Metzger's median patient age at 76, with 45% women.

In 2024, Dr. Metzger wrote 7,383 Medicare Part D claims for 1,159 patients. 81% of them were for generic drugs. CMS names the drug for 6,997 of them, across 68 drugs with 11 or more claims each, at $1,617,653 in total drug cost. In 2023, CMS named 6,676 claims across 66 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 99 out of 100 for Dr. Metzger for performance year 2024, reported through an alternative payment model (APM). Dr. Metzger accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Metzger as offering telehealth. CMS counts 64 procedures of varicose vein removal by Dr. Metzger, more than 78% of the clinicians it reports for that procedure.

CMS Open Payments shows 1,367 general payments to Dr. Metzger from 70 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 47% of the total. Boston Scientific Corporation paid the most, $17,993.

Dmand AI lists 2 awards for Dr. Metzger, most recently CMS Stage 1 EHR in 2013.

Dr. Metzger graduated from Tel Aviv University Sackler in 2000. Dr. Metzger is a member of ACC.

Dr. Metzger is in network with 15 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. Medicare plans come from the most carriers, 11. Check the plan with the practice before a visit.